ReviewAdvances in therapy2020
New Technologies and Applications in Sacral Neuromodulation: An Update.
Review in Advances in therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions.Advances in therapy · 2021Pooled it
- Trial
- Sacral Neuromodulation for Refractory Overactive Bladder: Closing the Gaps in Anatomy, Mechanisms, and Parameter Selection.Advances in therapy · 2026Review
- Revision and Explantation After Permanent Sacral Neuromodulation for Overactive Bladder: A Systematic Review and Meta-Analysis.International urogynecology journal · 2026Review
- Low Anterior Resection Syndrome, Role of SNM?Clinics in colon and rectal surgery · 2025Review
- Article
- Relevance of Leg Rehabilitation to Modulating Neurogenic Lower Urinary Tract Symptoms: A Systematic Review.Bioengineering (Basel, Switzerland) · 2025Review
- Electroconvulsive therapy in a patient with an implanted sacral neurostimulator: a case report on safe administration and short-term outcomes.Frontiers in psychiatry · 2025Article
- Effectiveness and safety of electroacupuncture in female overactive bladder: a randomized controlled trial investigating sacral and tibial nerve modulation.Frontiers in medicine · 2025Article
- Efficacy and safety of sacral nerve root magnetic stimulation combined with solifenacin in female patients with overactive bladder.American journal of translational research · 2025Article
- Application of Augmented Reality for Accurate Punctures During Stage 1 Sacral Neuromodulation.International neurourology journal · 2024Article
- Awareness and barriers of sacral neuromodulation in women with overactive bladder.Archives of gynecology and obstetrics · 2024Article
- Article
- Sacral Neuromodulation: Device Improvement and Current Applications in Urology.Medicina (Kaunas, Lithuania) · 2024Review
- Updates in pelvic neuromodulation: the role of pelvic neuromodulation in pelvic disorders.Frontiers in urology · 2024Review
- Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study.Frontiers in neuroscience · 2024Article
- Pathways and parameters of sacral neuromodulation in rats.American journal of physiology. Renal physiology · 2023Article
- [Functional-neurosurgical treatment options for functional pelvic floor disorders : Value of sacral neuromodulation].Radiologie (Heidelberg, Germany) · 2023Review
- Evaluation of a compact 3 T MRI scanner for patients with implanted devices.Magnetic resonance imaging · 2023Article
- Percutaneous Tibial Nerve Stimulation in the Treatment of Refractory Idiopathic Overactive Bladder Syndrome: A Retrospective Cohort Study.Journal of clinical medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently rechargeable devices have been introduced for sacral neuromodulation (SNM) with conditional safety for full-body magnetic resonance imaging (MRI). Currently a recharge-free SNM device represents the standard implant; however, it is only approved for MRI head scans. As further new technologies with broader MRI capabilities are emerging, the advantages as well as disadvantages of both rechargeable versus recharge-free devices will be briefly discussed in this commentary from the perspective of patients, healthcare professionals, and providers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.